578 Appendices 417. Russ G, Leboulleux S, Leenhardt L, Hegedüs L. Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. European thyroid journal. 2014;3:154-163. https://doi.org/10.1159/000365289. 418. McRobbie DW, Moore EA, Graves MJ, Prince MR. MRI from Picture to Proton. 2 ed. Cambridge: Cambridge University Press; 2006. 419. Shi R, Yao Q, Wu L, Zhou Q, Lu Q, Gao R, et al. T2* mapping at 3.0T MRI for differentiation of papillary thyroid carcinoma from benign thyroid nodules. 2016;43:956-961. https://doi.org/https://doi.org/10.1002/jmri.25041. 420. Ben-David E, Sadeghi N, Rezaei MK, Muradyan N, Brown D, Joshi A, et al. Semiquantitative and Quantitative Analyses of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Thyroid Nodules. J Comput Assist Tomogr. 2015;39:855-859. https://doi.org/10.1097/rct.0000000000000304. 421. Sakat MS, Sade R, Kilic K, Gözeler MS, Pala O, Polat G, et al. The Use of Dynamic Contrast-Enhanced Perfusion MRI in Differentiating Benign and Malignant Thyroid Nodules. Indian journal of otolaryngology and head and neck surgery. 2019;71:706-711. https://doi.org/10.1007/s12070-018-1512-3. 422. Chung SR, Lee JH, Yoon RK, Sung TY, Song DE, Pfeuffer J, et al. Differentiation of follicular carcinomas from adenomas using histogram obtained from diffusion-weighted MRI. Clin Radiol. 2020;75:878.e813-878.e819. https://doi. org/10.1016/j.crad.2020.07.018. 423. Wu LM, Chen XX, Li YL, Hua J, Chen J, Hu J, et al. On the utility of quantitative diffusion-weighted MR imaging as a tool in differentiation between malignant and benign thyroid nodules. Academic radiology. 2014;21:355-363. https://doi. org/10.1016/j.acra.2013.10.008. 424. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. European biophysics journal. 2010;39:527-540. https://doi.org/10.1007/s00249-009-0517-y. 425. Minuto MN, Shintu L, Caldarelli S. Proteomics, and metabolomics: magnetic resonance spectroscopy for the presurgical screening of thyroid nodules. Curr Genomics. 2014;15:178-183. https://doi.org/10.2174/138920291599 9140404100701. 426. Jordan KW, Adkins CB, Cheng LL, Faquin WC. Application of magnetic-resonance-spectroscopy- based metabolomics to the fine-needle aspiration diagnosis of papillary thyroid carcinoma. Acta Cytol. 2011;55:584-589. https://doi. org/10.1159/000333271. 427. Lean CL, Delbridge L, Russell P, May GL, Mackinnon WB, Roman S, et al. Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab. 1995;80:1306-1311. https://doi. org/10.1210/jcem.80.4.7714105. 428. Mackinnon WB, Delbridge L, Russell P, Lean CL, May GL, Doran S, et al. Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms. World J Surg. 1996;20:841-847. https://doi. org/10.1007/s002689900128. 429. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. Am J Med. 1994;96:383-388. https://doi. org/10.1016/0002-9343(94)90071-x. 430. King AD, Yeung DKW, Ahuja AT, Tse GMK, Chan ABW, Lam SSL, et al. In vivo 1H MR spectroscopy of thyroid carcinoma. Eur J Radiol. 2005;54:112-117. https://doi.org/https://doi.org/10.1016/j.ejrad.2004.05.003. 431. Gupta N, Kakar AK, Chowdhury V, Gulati P, Shankar LR, Vindal A. Magnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroid. Eur J Radiol. 2007;64:414-418. https://doi.org/10.1016/j.ejrad.2007.03.006. 432. Gupta N, Goswami B, Chowdhury V, RaviShankar L, Kakar A. Evaluation of the Role of Magnetic Resonance Spectroscopy in the Diagnosis of Follicular Malignancies of Thyroid. Arch Surg. 2011;146:179-182. https://doi. org/10.1001/archsurg.2010.345. 433. Aghaghazvini L, Pirouzi P, Sharifian H, Yazdani N, Kooraki S, Ghadiri A, et al. 3T magnetic resonance spectroscopy as a powerful diagnostic modality for assessment of thyroid nodules. Archives of endocrinology and metabolism. 2018;62:501-505. https://doi.org/10.20945/2359-3997000000069. 434. Cecil KM. Proton magnetic resonance spectroscopy: technique for the neuroradiologist. Neuroimaging Clin N Am. 2013;23:381-392. https://doi.org/10.1016/j.nic.2012.10.003. 435. Aydin H, Kizilgoz V, Tatar I, Damar C, Guzel H, Hekimoglu B, et al. The role of proton MR spectroscopy and apparent diffusion coefficient values in the diagnosis of malignant thyroid nodules: preliminary results. Clin Imaging. 2012;36:323-333. https://doi.org/10.1016/j.clinimag.2011.09.009. 436. Sasaki M, Sumi M, Kaneko K, Ishimaru K, Takahashi H, Nakamura T. Multiparametric MR imaging for differentiating between benign and malignant thyroid nodules: initial experience in 23 patients. J Magn Reson Imaging. 2013;38:6471. https://doi.org/10.1002/jmri.23948. 437. Noda Y, Kanematsu M, Goshima S, Kondo H, Watanabe H, Kawada H, et al. MRI of the thyroid for differential diagnosis of benign thyroid nodules and papillary carcinomas. AJR American journal of roentgenology. 2015;204:W332-335. https://doi.org/10.2214/ajr.14.13344.
RkJQdWJsaXNoZXIy MTk4NDMw